CLINICAL_TRIALS
trial_result
· 2013-04-04
Clinical Trial Update: Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer [Phase 2]
Summary
A Phase 2 trial evaluating Erlotinib for advanced non-small cell lung cancer has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Vanderbilt-Ingram Cancer Center | Conditions: Lung Cancer | Phase 2 | Status: COMPLETED